Pasithea Therapeutics Corp. Annual Share-based Payment Arrangement, Expense in USD from 2021 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Pasithea Therapeutics Corp. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2021 to 2023.
  • Pasithea Therapeutics Corp. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $121K, a 18.6% increase year-over-year.
  • Pasithea Therapeutics Corp. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $176K.
  • Pasithea Therapeutics Corp. annual Share-based Payment Arrangement, Expense for 2023 was $72K.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $72K Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
2021 $641K Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.